Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease

Pharmacogenomics Journal

Volumn 14, Issue 6, 2014, Pages 526-534

  Bank, S ^a,b   Andersen, P S ^c   Burisch, J ^d   Pedersen, N ^d   Roug, S ^e   Galsgaard, J ^f   Turino, S Y ^g   Brodersen, J B ^h   Rashid, S ⁱ   Rasmussen, B K ^j   Avlund, S ^k   Olesen, T B ^l   Hoffmann, H J ^k   Thomsen, M K ^k   Thomsen, V O ^c   Frydenberg, M ^b   Nexo B A ^b   Sode, J ^c,m,n   Vogel, U ^o   Andersen, V ^a,m,p,q  

^a VIBORG HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

^f KØGE HOSPITAL   (Denmark)

^g HILLERØD HOSPITAL   (Denmark)

^h ESBJERG HOSPITAL   (Denmark)

ⁱ BISPEBJERG HOSPITAL   (Denmark)

^j NYKØBING FALSTER HOSPITAL   (Denmark)

^k AARHUS UNIVERSITY HOSPITAL   (Denmark)

^l SLAGELSE HOSPITAL   (Denmark)

^m UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

ⁿ FREDERIKSBERG HOSPITAL   (Denmark)

^o NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^p Hospital of Southern Jutland   (Denmark)

^q ODENSE UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CD14 GENE; CHILD; CONTROLLED STUDY; CROHN DISEASE; DANISH CITIZEN; DRUG RESPONSE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; IFNG GENE; IL17A GENE; IL1B GENE; IL1RN GENE; IL6 GENE; LY96 GENE; MAJOR CLINICAL STUDY; MALE; MAP3K14 GENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TLR2 GENE; TLR4 GENE; TLR9 GENE; TNFA GENE; TNFAIP3 GENE; TNFRSF1A GENE; ULCERATIVE COLITIS; ANTAGONISTS AND INHIBITORS; COHORT ANALYSIS; DENMARK; DRUG EFFECTS; GENETICS; INFLAMMATORY BOWEL DISEASES; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NF-KAPPA B; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84927177410     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2014.19     Document Type: Article

References (56)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429.
2. http://www.bu.edu/nf-kb/gene-resources/target-genes/.
3. Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci 2008; 65: 2964-2978.
4. Komatsu M, Kobayashi D, Saito K, Furuya D, Yagihashi A, Araake H et al. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin Chem 2001; 47: 1297-1301.
5. Dionne S, Hiscott J, D'Agata I, Duhaime A, Seidman EG. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci 1997; 42: 1557-1566.
6. Meena NK, Verma R, Verma N, Ahuja V, Paul J. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis. J Clin Gastroenterol 2013; 47: 773-780.
7. Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 1993; 30: 1443-1453.
8. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-2476.
9. Mascheretti S, Hampe J, Kuhbacher T, Herfarth H, Krawczak M, Folsch UR et al. Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab. Pharmacogenomics J 2002; 2: 127-136.
10. Ljung T, Karlen P, Schmidt D, Hellstrom PM, Lapidus A, Janczewska I et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut 2004; 53: 849-853.
11. Caspersen S, Elkjaer M, Riis L, Pedersen N, Mortensen C, Jess T et al. Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and followup evaluation of malignancy and mortality. Clin Gastroenterol Hepatol 2008; 6: 1212-1217.
12. Cohen RD, Tsang JF, Hanauer SB. Infliximab in Crohn's disease: first anniversary clinical experience. Am J Gastroenterol 2000; 95: 3469-3477.
13. Bank S, Nexo BA, Andersen V, Vogel U, Andersen PS. High-quality and -quantity DNA extraction from frozen archival blood clots for genotyping of singlenucleotide polymorphisms. Genet Test Mol Biomarkers 2013; 17: 501-503.
14. http://pngu.mgh.harvard.edu/Bpurcell/gpc/.
15. Gu W, Shan YA, Zhou J, Jiang DP, Zhang L, Du DY et al. Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2. Ann Surg 2007; 246: 151-158.
16. Bielinski SJ, Hall JL, Pankow JS, Boerwinkle E, Matijevic-Aleksic N, He M et al. Genetic variants in TLR2 and TLR4 are associated with markers of monocyte activation: the Atherosclerosis Risk in Communities MRI Study. Hum Genet 2011; 129: 655-662.
17. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism∗ in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20: 976-983.
18. Mertens J, Bregadze R, Mansur A, Askar E, Bickeboller H, Ramadori G et al. Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity. J Mol Med (Berl) 2009; 87: 815-824.
19. Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y et al. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 2007; 66: 905-909.
20. Omar AH, Yasunami M, Yamazaki A, Shibata H, Ofori MF, Akanmori BD et al. Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study. Malar J 2012; 11: 168.
21. Thair SA, Walley KR, Nakada TA, McConechy MK, Boyd JH, Wellman H et al. A single nucleotide polymorphism in NF-kappaB inducing kinase is associated with mortality in septic shock. J Immunol 2011; 186: 2321-2328.
22. Knight JC, Keating BJ, Kwiatkowski DP. Allele-specific repression of lymphotoxinalpha by activated B cell factor-1. Nat Genet 2004; 36: 394-399.
23. Migita O, Noguchi E, Koga M, Jian Z, Shibasaki M, Migita T et al. Haplotype analysis of a 100 kb region spanning TNF-LTA identifies a polymorphism in the LTA promoter region that is associated with atopic asthma susceptibility in Japan. Clin Exp Allergy 2005; 35: 790-796.
24. Tan W, Wu H, Zhao J, Derber LA, Lee DM, Shadick NA et al. A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis. Arthritis Rheum 2010; 62: 2864-2875.
25. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 2000; 114: 1180-1183.
26. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006; 15: 519-529.
27. Elsby LM, Orozco G, Denton J, Worthington J, Ray DW, Donn RP. Functional evaluation of TNFAIP3 (A20) in rheumatoid arthritis. Clin Exp Rheumatol 2010; 28: 708-714.
28. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000; 61: 863-866.
29. Yoshida M, Shiroiwa K, Mouri K, Ishiguro H, Supriyanto I, Ratta-Apha W et al. Haplotypes in the expression quantitative trait locus of interleukin-1beta gene are associated with schizophrenia. Schizophr Res 2012; 140: 185-191.
30. Smith AJ, D'Aiuto F, Palmen J, Cooper JA, Samuel J, Thompson S et al. Association of serum interleukin-6 concentration with a functional IL6 -6331T4C polymorphism. Clin Chem 2008; 54: 841-850.
31. Lind H, Haugen A, Zienolddiny S. Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells. Cytokine 2007; 38: 43-48.
32. Wen AQ, Gu W, Wang J, Feng K, Qin L, Ying C et al. Clinical relevance of IL-1beta promoter polymorphisms (-1470, -511, and -31) in patients with major trauma. Shock 2010; 33: 576-582.
33. Rafiq S, Stevens K, Hurst AJ, Murray A, Henley W, Weedon MN et al. Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun 2007; 8: 344-351.
34. Rafiq S, Frayling TM, Murray A, Hurst A, Stevens K, Weedon MN et al. A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects. Genes Immun 2007; 8: 552-559.
35. Lacruz-Guzman D, Torres-Moreno D, Pedrero F, Romero-Cara P, Garcia-Tercero I, Trujillo-Santos J et al. Influence of polymorphisms and TNF and IL1beta serum concentration on the infliximab response in Crohn's disease and ulcerative colitis. Eur J Clin Pharmacol 2013; 69: 431-438.
36. Zhang F, Gao XD, Wu WW, Gao Y, Zhang YW, Wang SP. Polymorphisms in toll-like receptors 2, 4 and 5 are associated with Legionella pneumophila infection. Infection 2013; 41: 941-948.
37. Espinoza JL, Takami A, Nakata K, Onizuka M, Kawase T, Akiyama H et al. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One 2011; 6: e26229.
38. Gast A, Bermejo JL, Claus R, Brandt A, Weires M, Weber A et al. Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival. PLoS One 2011; 6: e24370.
39. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 2003; 198: 1563-1572.
40. Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004; 36: 837-841.
41. Song S, Chen D, Lu J, Liao J, Luo Y, Yang Z et al. NFkappaB1 and NFkappaBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS One 2011; 6: e21726.
42. Wang S, Zhang M, Zeng Z, Tian L, Wu K, Chu J et al. IkappaBalpha polymorphisms were associated with increased risk of gastric cancer in a southern Chinese population: a case-control study. Life Sci 2011; 88: 792-797.
43. Park JY, Farrance IK, Fenty NM, Hagberg JM, Roth SM, Mosser DM et al. NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives. Am J Physiol Heart Circ Physiol 2007; 293: H2320-H2327.
44. Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B et al. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol 2000; 20: 9113-9119.
45. Lv K, Chen R, Cai Q, Fang M, Sun S. Effects of a single nucleotide polymorphism on the expression of human tumor necrosis factor-alpha. Scand J Immunol 2006; 64: 164-169.
46. Karimi M, Goldie LC, Cruickshank MN, Moses EK, Abraham LJ. A critical assessment of the factors affecting reporter gene assays for promoter SNP function: a reassessment of -308 TNF polymorphism function using a novel integrated reporter system. Eur J Hum Genet 2009; 17: 1454-1462.
47. Wang GB, Li CR, Yang J, Wen PQ, Jia SL. A regulatory polymorphism in promoter region of TNFR1 gene is associated with Kawasaki disease in Chinese individuals. Hum Immunol 2011; 72: 451-457.
48. Carrol ED, Payton A, Payne D, Miyajima F, Chaponda M, Mankhambo LA et al. The IL1RN promoter rs4251961 correlates with IL-1 receptor antagonist concentrations in human infection and is differentially regulated by GATA-1. J Immunol 2011; 186: 2329-2335.
49. Wallis SK, Cooney LA, Endres JL, Lee MJ, Ryu J, Somers EC et al. A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis. Arthritis Res Ther 2011; 13: R15.
50. Rees LE, Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW. The interleukin- 10-1082 G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci 2002; 59: 560-569.
51. Andersen V, Ernst A, Christensen J, Ostergaard M, Jacobsen BA, Tjonneland A et al. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Med Genet 2010; 11: 82.
52. Oosting M, ter HH, van de Veerdonk FL, Sturm P, Kullberg BJ, van der Meer JW et al. Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease. Infect Immun 2011; 79: 4681-4687.
53. Shah R, Hurley CK, Posch PE. A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c. -1347C 4 T). Hum Genet 2006; 120: 461-469.
54. Kariuki SN, Crow MK, Niewold TB. The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus. Arthritis Rheum 2008; 58: 2818-2823.
55. Aoyagi Y, Nagata S, Kudo T, Fujii T, Wada M, Chiba Y et al. Peroxisome proliferatoractivated receptor gamma 2 mutation may cause a subset of ulcerative colitis. Pediatr Int 2010; 52: 729-734.
56. Hitomi Y, Ebisawa M, Tomikawa M, Imai T, Komata T, Hirota T et al. Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. J Allergy Clin Immunol 2009; 124: 779-785.